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Abstract
We conducted a molecular study of MRSA isolated in Swiss
hospitals, including the first five consecutive isolates recovered from
blood cultures and the first ten isolates recovered from other sites
in newly identified carriers. Among 73 MRSA isolates, 44 different
double locus sequence typing (DLST) types and 32 spa types were
observed. Most isolates belonged to the NewYork/Japan, the UK-
EMRSA-15, the South German and the Berlin clones. In a country
with a low to moderate MRSA incidence, inclusion of non-invasive
isolates allowed a more accurate description of the diversity.
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According to the European Antimicrobial Resistance Surveil-
lance Network (EARS-Net) data (www.ecdc.europa.eu), the
proportion of invasive Staphylococcus aureus isolates that were
found to be methicillin resistant (MRSA) in European countries
varied from below 5% to more than 50% in 2010. Switzerland
is not included in the EARS-Net but has a national surveillance
programme for antibiotic resistance (www.anresis.ch). Overall
the proportion of MRSA in clinical specimens was 9% in 2010
and 8% in 2011, varying from 4% in central Switzerland to 14%
in western Switzerland.
Clonal lineages can be identified by molecular typing. Thus it
is possible to follow the epidemiology and spread of major
clones [1,2]. A molecular epidemiological analysis conducted in
2006–2007 showed that MRSA spa types had a predominantly
regional distribution in Europe [3]. Switzerland was not
included in this study and no nationwide molecular data were
available since the last national study conducted in 1997 [4].
The objective of the present study was to assess the current
molecular epidemiology of MRSA in Swiss hospitals.
Between January and June 2011, we conducted a survey of
MRSA isolates collected in five > 500-bed Swiss hospitals
(Basel, Bern, Lausanne, Luzern and Z€urich). Hospitals from the
Italian-speaking region (Ticino) were also included and con-
sidered as one centre. Participating hospitals had an incidence
of new MRSA cases varying from below 1 to 18 per 1000
admissions (Table 1). Laboratories of participating centres
were asked to collect up to five consecutive MRSA isolates
from blood cultures in individual patients and the first ten
consecutive MRSA isolates from clinical samples other than
blood or from screening samples in newly identified MRSA
carriers (one isolate per carrier). All isolates were sent to one
reference centre (Lausanne). Molecular analysis of MRSA
strains was carried out by double locus sequence typing
(DLST, a method based on the analysis of the highly variable
regions of the clfB and spa genes) [5], spa-typing [6] and
SCCmec typing [7]. The presence of Panton-Valentine leuko-
cidin (PVL) genes was also investigated as described previously
[8].
A total of 74 isolates were sent to the reference centre: 14
isolates from blood cultures (1–5 per centre) and 60 isolates
from clinical or screening samples (ten per centre). One isolate
was found to be mecA negative (probable borderline oxacillin-
resistant S. aureus; BORSA) and was excluded from the
analysis. Depending on the hospitals’ MRSA incidence, 9 days
to 3 months were needed to obtain isolates from ten newly
identified patients.
The median age of patients was 63 years (range 1–99).
Forty-eight (66%) were male. At the time of bacteraemia or
first MRSA identification, 35 patients were hospitalized in
wards, seven in intensive care units, and 21 in emergency
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rooms or outpatient clinic; information was missing for 10
patients. Among the 14 patients with MRSA bacteraemia, four
(29%) died within 14 days (all-cause mortality); ten episodes
(71%) were hospital-onset bacteraemia.
Among the 73 MRSA isolates, 44 different DLST types (3–
11 per hospital) and 32 spa types (2–9 per hospital) were
observed (Table 1). Only 10 DLST types were shared by more
than one patient (2–12 patients). Nine different DLST types
were found among the 14 MRSA strains isolated from blood
cultures, whereas 38 different DLST types were found in the
59 other isolates.
Double locus sequence typing types were compared with
typing data of international clones [7,8]. At least 62 out of 74
(84%) MRSA isolates were related to 11 international clones
(Table 2). Most of them belonged to the New York/Japan
(ST5/105-SCCmec II-PVL neg; n = 16), the UK-EMRSA-15
(ST22-IV-neg; n = 15), the South German (ST228-I-neg;
n = 14) and the Berlin (ST45-IV-neg; n = 4) clones. These
data are consistent with the major international clones
recovered in Europe [2]. However, the major clones currently
observed in Swiss hospitals were different to those observed
in 1997, except for the Berlin clone [9]. This illustrates a
change in the molecular epidemiology of MRSA in Switzerland.
The genetic diversity encountered within each centre varied
according to the local epidemiology of MRSA. In the hospital
with the highest MRSA incidence, 12 out of 15 isolates had the
same DLST type, indicating a large clonal outbreak in this
centre. In contrast, hospitals with a lower incidence showed a
higher genetic diversity, suggesting a non-clonal spread of
MRSA in these centres.
In this study, MRSA isolates were collected in a few eligible
centres with a low to moderate MRSA incidence during a
limited period of time. Thus, only a few invasive isolates were
analysed. Inclusion of non-invasive isolates allowed more
isolates to be collected and a more accurate description of
the diversity to be obtained. Moreover, consecutive isolates
were collected and the diversity observed in a hospital facing a
clonal MRSA outbreak (such as centre 1) was probably not
representative of the real diversity observed year-round.
This study suggests that a national surveillance programme
could be easily implemented. Molecular analysis of ten isolates
per centre per year recovered throughout the whole year
should reflect the diversity of locally circulating MRSA clones.
Only isolates of newly diagnosed MRSA cases (carriers or
infected patients) should be included to better describe the
incidence of circulating clones at the present time. The DLST
method allows the simultaneous analysis of 96 isolates in
3 days for an estimated cost of 20 euros per isolate and is
therefore well suited for that purpose.
In conclusion, this study represents a recent update on the
genetic diversity of MRSA observed in Switzerland. At least 11
international clones were recovered from the six participating
centres. The small number of invasive isolates recovered in
TABLE 1. Epidemiological data of
participating centres
Centre 1 2 3 4 5 6 Total
Admissions (n)a 36 112 37 958 31 149 34 630 38 924 36 454 215 227
New MRSA cases/1000 admissionsa 18.05 0.63 1.09 1.24 1.95 1.34 4.15
Bacteraemia due to MRSA/1000 admissionsa 1.27 0.11 0.06 0.06 0.18 0.03 0.29
MRSA isolates (n) 15 13 10 10 15 10 73
Blood cultures 5 3 0 1 5 0 14
Otherb 10 10 10 9 10 10 59
DLST types (n) 3 9 10 10 11 9 44
spa types (n) 2 9 9 8 8 9 32
aIn 2010.
bIncluding screening samples.
DLST, double locus sequence typing; MRSA, methicillin-resistant Staphylococcus aureus.
TABLE 2. International clones recovered in Switzerland
International clone
(ST, SCCmec, PVL) Centres DLST types (n)
spa
Types
New York/Japan (ST5/105-II-neg) 1, 2, 3, 4, 5, 6 2-2 (9) t002
2-80 (3) t003
2-414 (1) t586
586-2 (1) t002
665-80 (1) t003
666-80 (1) t003
UK EMRSA-15 (ST22-IV-neg) 1, 4, 5 32-346 (2) t8849
32-211 (2) t515
32-623 (2) t2231
32-627 (1) t2440
32-341 (1) t3130
32-626 (3) t4640
32-628 (1) t7478
251-211 (1) t515
663-211 (1) t515
664-211 (1) t515
South German (ST228-I-neg) 1, 2, 6 4-4 (12) t041
4-338 (1) t579
4-618 (1) ND
Berlin (ST45-IV-neg) 2, 3, 4, 6 1-198 (1) t050
121-198 (1) t050
641-37 (1) t015
389-11 (1) t065
European CA-MRSA (ST80-IV-pos) 4, 6 7-26 (2) t044
646-26 (1) t044
WA-MRSA-2 (ST88-IV-pos) 2, 3 69-63 (1) t786
604-409 (1) t692
653-287 (1) t690
Lyon (ST8-IV-neg) 3 658-3 (1) t008
100-3 (1) t008
Brazilian (ST239-IIImerc.-neg) 5 660-30 (2) t037
WA-MRSA-1 (ST1-IV-neg) 4 5-46 (1) t127
Southwest pacific (ST30-IV-pos) 2 51-94 (1) t318
Livestock associated (ST398-V-neg) 4 245-339 (1) t034
ST, sequence type according to the multilocus sequence typing (MLST) scheme; N,
number of isolates; ND, not determined; DLST, double locus sequence typing.
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centres with a low MRSA incidence would not have allowed an
accurate description of the local diversity. Adding non-invasive
isolates represented a good alternative in settings with low
MRSA incidence.
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